{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:01:41Z","timestamp":1784707301489,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10787-026-02293-4","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:38:06Z","timestamp":1781678286000},"page":"4733-4751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroinflammation mediated repurposing of clemastine for Alzheimer\u2019s disease through network pharmacology, molecular dynamics, and experimental validation studies"],"prefix":"10.1007","volume":"34","author":[{"given":"Simran","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinjini","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratigya","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyamvada","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2293_CR1","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1016\/j.compbiomed.2025.111318","volume":"199","author":"SI Alzarea","year":"2025","unstructured":"Alzarea SI, Alsaidan OA, Qasim S et al (2025) A network pharmacology and in silico approach to target NEU1-mediated microglial activation in neuroinflammation: validation in an LPS-induced mouse model. Comput Biol Med 199:5314. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111318","journal-title":"Comput Biol Med"},{"key":"2293_CR2","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/molecules29225314","volume":"29","author":"VT Angelova","year":"2024","unstructured":"Angelova VT, Stoyanov BP, Simeonova R (2024) New insights into the development of donepezil-based hybrid and natural molecules as multi-target drug agents for Alzheimer\u2019s disease treatment. Molecules 29:5314","journal-title":"Molecules"},{"key":"2293_CR3","doi-asserted-by":"publisher","first-page":"34882","DOI":"10.1038\/s41598-025-17343-0","volume":"15","author":"M Azmal","year":"2025","unstructured":"Azmal M, Paul JK, Talukder OF et al (2025) Computational identification of phytochemicals as glycogen synthase kinase 3 beta (GSK3\u03b2) inhibitors for therapeutic applications in chronic diseases. Sci Rep 15:34882. https:\/\/doi.org\/10.1038\/s41598-025-17343-0","journal-title":"Sci Rep"},{"key":"2293_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-023-01206-2","volume":"15","author":"A Boeddrich","year":"2023","unstructured":"Boeddrich A, Haenig C, Neuendorf N et al (2023) A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer\u2019s disease. Genome Med 15:50. https:\/\/doi.org\/10.1186\/s13073-023-01206-2","journal-title":"Genome Med"},{"issue":"9","key":"2293_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/antiox1009","volume":"10","author":"FR Buccellato","year":"2021","unstructured":"Buccellato FR, D\u2019Anca M, Fenoglio C, Scarpini E, Galimberti D (2021) Role of oxidative damage in Alzheimer\u2019s disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery. Antioxidants 10(9):1353. https:\/\/doi.org\/10.3390\/antiox1009","journal-title":"Antioxidants"},{"key":"2293_CR6","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1038\/s41598-022-09270-1","volume":"12","author":"N Curdt","year":"2022","unstructured":"Curdt N, Schmitt FW, Bouter C et al (2022) Search strategy analysis of Tg4\u201342 Alzheimer Mice in the Morris Water Maze reveals early spatial navigation deficits. Sci Rep 12:5451. https:\/\/doi.org\/10.1038\/s41598-022-09270-1","journal-title":"Sci Rep"},{"key":"2293_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/2211-5463.12428","volume":"8","author":"Z Dai","year":"2018","unstructured":"Dai Z, Tang H, Pan Y et al (2018) Gene expression profiles and pathway enrichment analysis of human osteosarcoma cells exposed to sorafenib. FEBS Open Bio 8:860\u2013867. https:\/\/doi.org\/10.1002\/2211-5463.12428","journal-title":"FEBS Open Bio"},{"key":"2293_CR8","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.3390\/molecules29184354","volume":"29","author":"J Detka","year":"2024","unstructured":"Detka J, P\u0142achtij N, Strzelec M et al (2024) p38\u03b1 mitogen-activated protein kinase\u2014an emerging drug target for the treatment of Alzheimer\u2019s disease. Molecules 29:4354","journal-title":"Molecules"},{"key":"2293_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bbr.2015.01.042","volume":"286","author":"S Dhanda","year":"2015","unstructured":"Dhanda S, Sandhir R (2015) Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. Behav Brain Res 286:222\u2013235. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.042","journal-title":"Behav Brain Res"},{"key":"2293_CR10","doi-asserted-by":"publisher","first-page":"1254230","DOI":"10.3389\/fmolb.2023.1254230","volume":"10","author":"EI Edache","year":"2023","unstructured":"Edache EI, Uzairu A, Mamza PA et al (2023) Combining docking, molecular dynamics simulations, AD-MET pharmacokinetics properties, and MMGBSA calculations to create specialized protocols for running effective virtual screening campaigns on the autoimmune disorder and SARS-CoV-2 main protease. Front Mol Biosci 10:1254230. https:\/\/doi.org\/10.3389\/fmolb.2023.1254230","journal-title":"Front Mol Biosci"},{"key":"2293_CR100","doi-asserted-by":"publisher","unstructured":"Filippov MA, Tatarnikova OG, Pozdnyakova NV, Vorobyov VV (2021) Inflammation\/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls. Neural Regener Res 16(2):223\u2013233. https:\/\/doi.org\/10.4103\/1673-5374.290878","DOI":"10.4103\/1673-5374.290878"},{"key":"2293_CR11","doi-asserted-by":"publisher","first-page":"W32","DOI":"10.1093\/nar\/gku293","volume":"42","author":"D Gfeller","year":"2014","unstructured":"Gfeller D, Grosdidier A, Wirth M et al (2014) SwissTargetPrediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res 42:W32\u2013W38. https:\/\/doi.org\/10.1093\/nar\/gku293","journal-title":"Nucleic Acids Res"},{"key":"2293_CR12","doi-asserted-by":"publisher","first-page":"1279985","DOI":"10.3389\/fnmol.2023.1279985","volume":"16","author":"S Jiang","year":"2023","unstructured":"Jiang S, Wang X, Cao T et al (2023) Insights on therapeutic potential of clemastine in neurological disorders. Front Mol Neurosci 16:1279985","journal-title":"Front Mol Neurosci"},{"key":"2293_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ibneur.2025.05.005","volume":"18","author":"P Kamila","year":"2025","unstructured":"Kamila P, Kar K, Chowdhury S et al (2025) Effect of neuroinflammation on the progression of Alzheimer\u2019s disease and its significant ramifications for novel anti-inflammatory treatments. IBRO Neurosci Rep 18:771\u2013782","journal-title":"IBRO Neurosci Rep"},{"key":"2293_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"BH Kim","year":"2025","unstructured":"Kim BH, Kim S, Nam Y et al (2025) Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Transl Neurodegener 14:140","journal-title":"Transl Neurodegener"},{"key":"2293_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12974-019-1524-2","volume":"16","author":"T Li","year":"2019","unstructured":"Li T, Chen X, Zhang C et al (2019) An update on reactive astrocytes in chronic pain. J Neuroinflammation 16:140","journal-title":"J Neuroinflammation"},{"key":"2293_CR16","doi-asserted-by":"publisher","first-page":"113742","DOI":"10.1016\/j.expneurol.2021.113742","volume":"342","author":"ZY Li","year":"2021","unstructured":"Li ZY, Chen LH, Zhao XY et al (2021) Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy. Exp Neurol 342:113742. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113742","journal-title":"Exp Neurol"},{"key":"2293_CR17","doi-asserted-by":"publisher","unstructured":"Maria Beatrice Passani C, Provensi G, Costa A, et al (2018) Themed section: new uses for 21st century brain histamine modulates recognition memory: possible implications in major cognitive disorders. https:\/\/doi.org\/10.1111\/bph.v177.3\/issuetoc","DOI":"10.1111\/bph.v177.3\/issuetoc"},{"key":"2293_CR18","doi-asserted-by":"crossref","unstructured":"Niazi SK, Magoola M, Mariam Z (2024) Synergistic approaches in neurodegenerative therapeutics: multi-target drug innovative interventions for Alzheimer\u2019s disease","DOI":"10.20944\/preprints202402.1734.v1"},{"key":"2293_CR19","doi-asserted-by":"publisher","first-page":"e32723","DOI":"10.1002\/brb3.2723","volume":"12","author":"A Nooraei","year":"2022","unstructured":"Nooraei A, Khazaeel K, Darvishi M et al (2022) Dimorphic evaluation of hippocampal changes in rat model of demyelination: a comparative functional, morphometric, and histological study. Brain Behav 12:e32723. https:\/\/doi.org\/10.1002\/brb3.2723","journal-title":"Brain Behav"},{"key":"2293_CR20","doi-asserted-by":"publisher","first-page":"1459025","DOI":"10.3389\/fnagi.2024.1459025","volume":"16","author":"J Pan","year":"2024","unstructured":"Pan J, Yao Q, Wang Y et al (2024) The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci 16:1459025","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"2293_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0306-4522(97)00353-9","volume":"82","author":"P Panula","year":"1997","unstructured":"Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, Relja M (1997) Neuronal histamine deficit in Alzheimer\u2019s disease. Neuroscience 82(4):993\u2013997","journal-title":"Neuroscience"},{"key":"2293_CR22","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.6c00045","author":"D Patel","year":"2026","unstructured":"Patel D, Soni R, Bhogal I et al (2026) Phosphatidylinositol-3-kinase\/protein kinase B (PI3K\/AKT) and nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome modulation underlies the neuroprotective effects of vildagliptin in a rotenone-induced mouse model of Parkinson\u2019s disease. ACS Pharmacol Transl Sci. https:\/\/doi.org\/10.1021\/acsptsci.6c00045","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2293_CR23","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","volume":"19","author":"J Pi\u00f1ero","year":"2021","unstructured":"Pi\u00f1ero J, Sa\u00fcch J, Sanz F, Furlong LI (2021) The DisGeNET cytoscape app: exploring and visualizing disease genomics data. Comput Struct Biotechnol J 19:2960\u20132967. https:\/\/doi.org\/10.1016\/j.csbj.2021.05.015","journal-title":"Comput Struct Biotechnol J"},{"key":"2293_CR24","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s12276-024-01261-8","volume":"56","author":"R Ramachandran","year":"2024","unstructured":"Ramachandran R, Manan A, Kim J, Choi S (2024) NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders. Exp Mol Med 56:1488\u20131500","journal-title":"Exp Mol Med"},{"key":"2293_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1212\/WNL.0000000000207757","volume":"101","author":"VK Ramanan","year":"2023","unstructured":"Ramanan VK, Armstrong MJ, Choudhury P et al (2023) Antiamyloid monoclonal antibody therapy for Alzheimer disease: emerging issues in neurology. Neurology 101:842\u2013852. https:\/\/doi.org\/10.1212\/WNL.0000000000207757","journal-title":"Neurology"},{"issue":"8","key":"2293_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","volume":"14","author":"M Rebhan","year":"1998","unstructured":"Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1998) GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14(8):656\u2013664","journal-title":"Bioinformatics"},{"key":"2293_CR27","doi-asserted-by":"publisher","first-page":"e12379","DOI":"10.1002\/trc2.12379","volume":"9","author":"A Satpati","year":"2023","unstructured":"Satpati A, Neylan T, Grinberg LT (2023) Histaminergic neurotransmission in aging and Alzheimer\u2019s disease: a review of therapeutic opportunities and gaps. Alzheimer\u2019s and Dementia Transl Res Clin Interv 9:e12379","journal-title":"Alzheimer\u2019s and Dementia Transl Res Clin Interv"},{"key":"2293_CR28","doi-asserted-by":"publisher","first-page":"9609","DOI":"10.1007\/s00210-025-03978-3","volume":"398","author":"S Soni","year":"2025","unstructured":"Soni S, Kaur G (2025) Emerging therapeutic application of clemastine: a review of recent patents updates. Naunyn Schmiedebergs Arch Pharmacol 398:9609\u20139622","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2293_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbr.2004.10.011","volume":"159","author":"NL Sparkman","year":"2005","unstructured":"Sparkman NL, Martin LA, Calvert WS, Boehm GW (2005) Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL\/6J mice. Behav Brain Res 159:145\u2013151. https:\/\/doi.org\/10.1016\/j.bbr.2004.10.011","journal-title":"Behav Brain Res"},{"key":"2293_CR30","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D et al (2019) STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Res"},{"key":"2293_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.insi.2026.100288","volume":"2","author":"KC Thombare","year":"2026","unstructured":"Thombare KC, Desai SA, Patel VP et al (2026) Molecular simulation-guided discovery and experimental validation of 7-Methoxyflavone as a selective FGFR4 inhibitor in hepatocellular carcinoma. In Silico Res Biomed 2:100288. https:\/\/doi.org\/10.1016\/j.insi.2026.100288","journal-title":"In Silico Res Biomed"},{"key":"2293_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.914153","author":"LY Tong","year":"2022","unstructured":"Tong LY, Deng YB, Du WH et al (2022) Clemastine promotes differentiation of oligodendrocyte progenitor cells through the activation of ERK1\/2 via muscarinic receptors after spinal cord injury. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.914153","journal-title":"Front Pharmacol"},{"key":"2293_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02612-w","author":"AFK Vizuete","year":"2022","unstructured":"Vizuete AFK, Fr\u00f3es F, Seady M et al (2022) Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-022-02612-w","journal-title":"J Neuroinflammation"},{"key":"2293_CR34","doi-asserted-by":"publisher","first-page":"11638","DOI":"10.3390\/ijms252111638","volume":"25","author":"B Wright","year":"2024","unstructured":"Wright B, King S, Suphioglu C (2024) The importance of phosphoinositide 3-Kinase in neuroinflammation. Int J Mol Sci 25:11638","journal-title":"Int J Mol Sci"},{"key":"2293_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.733945","author":"YY Xie","year":"2021","unstructured":"Xie YY, Pan TT, Xu DE et al (2021) Clemastine ameliorates myelin deficits via preventing senescence of oligodendrocytes precursor cells in Alzheimer\u2019s disease model mouse. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2021.733945","journal-title":"Front Cell Dev Biol"},{"key":"2293_CR36","doi-asserted-by":"publisher","first-page":"6688","DOI":"10.1038\/s41598-024-57224-6","volume":"14","author":"A Yilgor","year":"2024","unstructured":"Yilgor A, Demir C (2024) Determination of oxidative stress level and some antioxidant activities in refractory epilepsy patients. Sci Rep 14:6688. https:\/\/doi.org\/10.1038\/s41598-024-57224-6","journal-title":"Sci Rep"},{"key":"2293_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29770-3","author":"P Youssef","year":"2018","unstructured":"Youssef P, Chami B, Lim J et al (2018) Evidence supporting oxidative stress in a moderately affected area of the brain in Alzheimer\u2019s disease. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-29770-3","journal-title":"Sci Rep"},{"key":"2293_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267","journal-title":"Signal Transduct Target Ther"},{"key":"2293_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42286-8","author":"J Zhao","year":"2019","unstructured":"Zhao J, Bi W, Xiao S et al (2019) Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-42286-8","journal-title":"Sci Rep"},{"key":"2293_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X251382874","author":"X Zong","year":"2025","unstructured":"Zong X, Huang Z, Kong F et al (2025) Clemastine ameliorates cognitive deficits in an experimental rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab. https:\/\/doi.org\/10.1177\/0271678X251382874","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02293-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02293-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:16:02Z","timestamp":1784704562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02293-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2293"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02293-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"24 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}